Haleos Labs Limited (HALEOSLABS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002809, "name": "Haleos Labs Limi", "stock_name": "Haleos Labs Limi", "full_name": "Haleos Labs Limited", "name_url": "stocks-analysis/haleos-labs-limi", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,524.75", "chg": "0.00", "chgp": "0.00%", "dir": 0, "prev_price": "1,524.75", "mcapval": "466.00 Cr", "mcap": "Micro Cap", "scripcode": 540679, "symbol": "HALEOSLABS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE320X01016", "curr_date": "Sep 01, 03:30 PM", "curr_time": "10:43 AM", "last_traded_at": "Sep 01, 03:30 PM IST", "bse_nse_vol": "1.48 k", "exc_status": "Active", "traded_date": "Sep 01, 2026", "traded_date_str": "2026 09 01", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/haleos-labs-limi-1002809-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Haleos Labs Limited is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-sell-by-marketsmojo-4170126", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HaleosLabsLimit_mojoScore_4170126.png", "date": "2026-08-26 10:10:03", "description": "Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 26 August 2026, providing investors with the most recent and relevant data to assess the stock’s outlook." }, { "title": "Haleos Labs Limited is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-sell-4155185", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HaleosLabsLimit_mojoScore_4155185.png", "date": "2026-08-15 10:10:15", "description": "Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 15 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Haleos Labs Falls 4.66%: Quarterly Profit Drop and Market Pressure Weigh on Shares", "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-falls-466-quarterly-profit-drop-and-market-pressure-weigh-on-shares-4143155", "imagepath": "", "date": "2026-08-08 13:02:49", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Stock opens strong at Rs.1,582.85 (+3.79%)</p>\n <p><strong>5 Aug:</strong> Q1 FY27 results announced; profit plunges 36%</p>\n <p><strong>6 Aug:</strong> Financial trend worsens; stock dips to Rs.1,421.75 (-10.18%)</p>\n <p><strong>7 Aug:</strong> Modest recovery to Rs.1,454.05 (+1.04%) but weekly close down</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,582.85</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs...." }, { "title": "Are Haleos Labs Limited latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-haleos-labs-limited-latest-results-good-or-bad-4140385", "imagepath": "", "date": "2026-08-06 19:22:58", "description": "Haleos Labs Limited's latest financial results for the quarter ending June 2026 reflect significant operational challenges. The company reported consolidated net sales of ₹72.94 crores, which represents an 11.59% decline year-on-year, marking its weakest quarterly performance in recent memory. This decline in sales is indicative of persistent demand headwinds, as it also reflects a sequential decrease of 2.93% from the previous quarter.\n\nThe consolidated net profit for the quarter stood at ₹2.65 crores, showing a notable year-on-year decline of 36.30%. This decline is compounded by a contraction in the profit after tax (PAT) margin, which fell to 2.52% from 5.31% in the same quarter last year, highlighting severe profitability pressure. The operating margin, excluding other income, also contracted to 12.49%, down from 14.19% in the prior year, reflecting deteriorating operational leverage likely driven by r..." }, { "title": "Haleos Labs Limited Reports Sharp Decline in Quarterly Financials Amid Market Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/haleos-labs-limited-reports-sharp-decline-in-quarterly-financials-amid-market-pressure-4138989", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HaleosLabsLimit_fintrenddot_4138989.png", "date": "2026-08-06 08:00:26", "description": "Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a significant deterioration in its financial performance for the quarter ended June 2026. The company’s latest results reveal steep declines in profitability and sales, marking a shift from its previous trend and prompting a downgrade in its Mojo Grade to Sell." }, { "title": "Haleos Labs Q1 FY27: Profit Plunges 36% Amid Revenue Decline and Margin Pressure", "link": "https://www.marketsmojo.com/news/result-analysis/haleos-labs-q1-fy27-profit-plunges-36-amid-revenue-decline-and-margin-pressure-4138554", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HaleosLabsLimit_quaterlyResult_4138554.png", "date": "2026-08-05 19:47:47", "description": "Haleos Labs Limited reported a disappointing first quarter for FY27, with consolidated net profit declining 36.30% year-on-year to ₹2.65 crores from ₹4.16 crores in Q1 FY26. The micro-cap pharmaceutical company, with a market capitalisation of ₹469.00 crores, saw its stock tumble 10.18% following the results announcement, closing at ₹1,421.75 on August 5, 2026." }, { "title": "Haleos Labs Limited is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-sell-4135133", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HaleosLabsLimit_mojoScore_4135133.png", "date": "2026-08-04 10:10:22", "description": "Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Haleos Labs Limited is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-sell-4119176", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HaleosLabsLimit_mojoScore_4119176.png", "date": "2026-07-24 10:10:19", "description": "Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Haleos Labs Limited is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/haleos-labs-limited-is-rated-sell-4098391", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HaleosLabsLimit_mojoScore_4098391.png", "date": "2026-07-13 10:10:17", "description": "Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 466, "sid": "1002809", "stock_news_url": "https://www.marketsmojo.com/news/haleos-labs-limited-1002809" }, "announcements": [ { "caption": "Communication To Shareholders (TDS Related)", "datetime": "24-Aug-2026", "details": "Enclosed email communication sent to Shareholders.", "source": "BSE" }, { "caption": " Newspaper Publication (Financial Results)", "datetime": "07-Aug-2026", "details": "Enclosed -- newspaper advertisement for Q1F27 results.", "source": "BSE" }, { "caption": "Independent Directors (Reappointed)", "datetime": "05-Aug-2026", "details": "Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam were reappointed for a second term of 5 years w.e.f. November 13 2026 subject to approval of shareholders.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Haleos Labs Limited has declared <strong>15%</strong> dividend, ex-date: 24 Sep 25", "dt": "2025-09-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Stock opens strong at Rs.1,582.85 (+3.79%)

5 Aug: Q1 FY27 results announced; profit plunges 36%

6 Aug: Financial trend worsens; stock dips to Rs.1,421.75 (-10.18%)

7 Aug: Modest recovery to Rs.1,454.05 (+1.04%) but weekly close down

Read full news article

Are Haleos Labs Limited latest results good or bad?

2026-08-06 19:22:58

Haleos Labs Limited's latest financial results for the quarter ending June 2026 reflect significant operational challenges. The company reported consolidated net sales of ₹72.94 crores, which represents an 11.59% decline year-on-year, marking its weakest quarterly performance in recent memory. This decline in sales is indicative of persistent demand headwinds, as it also reflects a sequential decrease of 2.93% from the previous quarter. The consolidated net profit for the quarter stood at ₹2.65 crores, showing a notable year-on-year decline of 36.30%. This decline is compounded by a contraction in the profit after tax (PAT) margin, which fell to 2.52% from 5.31% in the same quarter last year, highlighting severe profitability pressure. The operating margin, excluding other income, also contracted to 12.49%, down from 14.19% in the prior year, reflecting deteriorating operational leverage likely driven by r...

Read full news article

Haleos Labs Limited Reports Sharp Decline in Quarterly Financials Amid Market Pressure

2026-08-06 08:00:26

Haleos Labs Limited, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a significant deterioration in its financial performance for the quarter ended June 2026. The company’s latest results reveal steep declines in profitability and sales, marking a shift from its previous trend and prompting a downgrade in its Mojo Grade to Sell.

Read full news article

Haleos Labs Q1 FY27: Profit Plunges 36% Amid Revenue Decline and Margin Pressure

2026-08-05 19:47:47

Haleos Labs Limited reported a disappointing first quarter for FY27, with consolidated net profit declining 36.30% year-on-year to ₹2.65 crores from ₹4.16 crores in Q1 FY26. The micro-cap pharmaceutical company, with a market capitalisation of ₹469.00 crores, saw its stock tumble 10.18% following the results announcement, closing at ₹1,421.75 on August 5, 2026.

Read full news article

Haleos Labs Limited is Rated Sell

2026-08-04 10:10:22

Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Haleos Labs Limited is Rated Sell

2026-07-24 10:10:19

Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Haleos Labs Limited is Rated Sell

2026-07-13 10:10:17

Haleos Labs Limited is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article